US pharmaceutical company Pfizer has begun Phase 1 clinical trial of a novel oral antiviral drug for SARS-CoV-2, the virus that causes Covid-19.
The oral...
Neutralizing antibodies induced by the Pfizer and Moderna Covid-19 vaccines were significantly less effective against the SARS-CoV-2 variants first described in Brazil/Japan and South...
Bharat Biotech on Wednesday announced the first interim analysis of Covaxin, which shows the efficacy of the Covid-19 vaccine to be at 81 percent.
The...
US-based drugmaker Moderna said that it has completed manufacturing of clinical trial material for its variant-specific vaccine candidate against the SARS-CoV-2 variant known as...
The genetic diagnostic laboratories in India have detected over 24,000 mutations in the strains of SARS-CoV-2 in the last year, top officials told IANS...
Billionaire Elon Musk has become a co-author of a study on Covid-19 where he joined researchers to track coronavirus infection in 4,000 SpaceX workers...
Researchers have discovered that SARS-CoV-2 can directly infect the central nervous system and have begun to unravel some of the virus's effects on brain...
Making a compelling case for the expected long-term effects on the brain and nervous system by the Covid virus, new research that included scientists...